My Stocks Explore Events Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Live today
{{event.ticker}} @{{event.event_utc_datetime | date:'h:mm a'}}
{{market.market_short_name}} {{market.last_price | number : 2}}
AlphaStreet

Want to join the conversation?


$ZTS {{ '2015-08-04T12:22:51+0000' | timeago}} • Announcement

$ZTS 2Q15 PR: The U.S. Department of Agriculture (USDA) granted ZTS a conditional license for a first-of-its-kind antibody therapy that targets interleukin-31 (IL-31) to help reduce clinical signs associated with atopic dermatitis in dogs.

User Amelita Yates {{ '2016-12-09T01:04:30+0000' | timeago}}

Guys, it’s finally official. $MSFT has closed the $LNKD acquisition. Way to go :)

User Lissie Sanders {{ '2016-12-09T00:25:25+0000' | timeago}}

$MON shares dip slightly; I wonder this is because of the environmental lawsuit filed by the Washington state against the production of PCBs.

User Irene Grennan {{ '2016-12-08T23:31:02+0000' | timeago}}

My bet is that $FR will reach $32 in the short term. It’s time it broke the 52-week high and had its fair share of growth.

User Floyd Jenks {{ '2016-12-08T23:18:11+0000' | timeago}}

Read a media report stating that good times are coming to an end for Dollar stores. If you ask me, there appears to be no cloud on the horizon and major Dollar stores like $DG and $DLTR are doing well for sure.

User Ted Owsley {{ '2016-12-08T22:55:10+0000' | timeago}}

$WYNN got bruised up by China after its decision to cut withdrawal limit in Macau ATMs. Wynn Resorts shares went down by more than 11%! Well who could have guessed that right?

$LLY {{ '2016-12-09T13:18:21+0000' | timeago}} • Announcement

$LLY and $AZN announced a worldwide agreement to co-develop MEDI1814 for potential disease-modifying treatment for Alzheimer's disease (AD). Under terms, $LLY will make a $30MM upfront payment to $AZN. $LLY will recognize upfront $30MM pretax or about $0.02 per share after-tax, as a charge to earnings in 4Q16.

$SCVL {{ '2016-12-09T13:17:46+0000' | timeago}} • Announcement

$SCVL said its BoD approved the payment of a quarterly cash dividend of $0.07 per share to be paid on January 23, 2017, to shareholders of record as of January 9, 2017.

$SCVL {{ '2016-12-09T13:17:25+0000' | timeago}} • Announcement

$SCVL said its BoD authorized a new share repurchase program for up to $50MM of its outstanding common stock, effective January 1, 2017. The new share repurchase program will replace the existing $50MM share repurchase program that was authorized on December 9, 2015, which will expire in accordance with its terms on December 31, 2016.

$LLY {{ '2016-12-09T13:16:09+0000' | timeago}} • Announcement

$LLY and $AZN announced a worldwide agreement to co-develop MEDI1814, an antibody selective for amyloid-beta 42, which is currently in Phase 1 trials as potential disease-modifying treatment for Alzheimer's disease (AD). This agreement builds on existing collaboration related to AZD3293, BACE inhibitor in two pivotal Phase 3 trials.

$JJSF {{ '2016-12-09T12:54:09+0000' | timeago}} • Announcement

$JJSF said its BoD has declared a regular quarterly cash dividend of $0.42 per share of its common stock payable on January 11, 2017 to shareholders of record as of December 21, 2016. The cash dividend of $0.42 per share represents an increase of 7.7% from the previous quarterly dividend rate of $0.39 per share.